Introduction
Stroke remains one of the leading causes of death and disability worldwide,1 with carotid stenosis being one of few directly modifiable causes. Carotid endarterectomy has been proven to be effective in reducing future risk of stroke in patients with symptomatic carotid stenosis, but only when performed in the subacute phase after a stroke or transitory ischaemic attack (TIA).2–4 Physical examination and auscultation are unable to detect a significant carotid stenosis accurately and reliably. Thus, it is recommended to routinely examine all patients with stroke or TIA with diagnostic imaging.5
Carotid duplex ultrasound is recommended as the first line examination for carotid stenosis due to its non-invasive nature. Other modalities serve as confirmatory and discretionary tests due to (1) the resource and time demands of magnetic resonance angiography, (2) the use of potentially nephrotoxic intravenous contrast and radiation by CT angiography (CTA) and (3) the procedural risk of stroke (conventional angiography).6 Still, conventional high-end ultrasound requires expensive and relatively stationary equipment, dedicated labs and trained personnel. As carotid stenosis is the underlying cause in only approximately 15% of patients with stroke or TIA, the resources and time invested to identify the patients who could benefit from carotid endarterectomy is significant.7 Thus, improving the selection of patients in need for more comprehensive carotid imaging would improve in-hospital logistics, which is a major contributor to delayed referral to carotid endarterectomy.8
Point-of-care ultrasound in general and hand-held ultrasound devices (HUDs) specifically have been increasingly adopted in diverse fields as primary care,9 cardiology10–14 and emergency medicine,15 bridging the gap between physical examination and advanced imaging modalities due to their ease of use, steadily increasing affordability and accessibility.16 The potential for improvement in hospital logistics and use of resources is significant,17 and specifically the potential for rapid ruling-out individuals not in need for further imaging would be beneficial. Thus, there is a need to rigorously evaluate the reliability of these novel tools before their adoption into new clinical arenas and, to our knowledge, this has not been studied in patients admitted with stroke or TIA. Thus, we aimed to investigate the agreement of HUD compared with standard of care high-end vascular ultrasound (HIGH) performed by cardiologists experienced in carotid ultrasound. Second, we aimed to compare the agreement between HUD and reference according to the burden of carotid disease and lastly to evaluate potential predictors for the reliability of the HUD examinations.